Prostacyclin (PGI2) synthase is a constitutively expressed enzyme in human endothelial cells

E. Spisni, G. Bartolini, M. Orlandi, B. Belletti, S. Santi, V. Tomasi

Research output: Contribution to journalArticle

Abstract

Biogenesis of prostanoids is under the control of some polypeptide growth factors. Cytosolic phospholipase A2, a form specific for arachidonic acid containing phospholipids, is activated by a translocation mechanism regulated by growth factors, while prostaglandin H synthase isoforms are induced de novo in several cell types. No information is available as far as PGI2 synthase is concerned. Human umbilical vein endothelial cells were cultured under conditions favoring proliferation or differentiation or capillary-like network formation in the presence of collagen gels. Basic fibroblast growth factor (bFGF 0.5-4 ng/ml) was used as a mitogen, interleukin-1α (IL-1α 10- 60 UI/ml) as a differentiating agent, and prostacyclin (PGI2) biosynthesis was evaluated. Under the first condition, basal PGI2 production was unaffected while, in the presence of IL-1α, a marked stimulation of PGI2 synthesis was observed. It is known that IL-1α is a potent inducer of PGH synthase, while it is not known whether PGI2 synthase is also induced. Two lines of evidence indicate that PGI2 synthase is a constitutively expressed not inducible enzyme: (a) proliferating nonproducing cells when added with PGH2 produce an amount of PGI2 not different from the amount produced by cells stimulated with IL-1α; (b) under this condition PGI2 synthase was immunodetectable either by immunofluorescence detected by confocal microscopy or by ELISA and, on microsomes isolated from endothelial cells, by Western blotting. It is concluded that the limiting step in the conversion arachidonate-PGI2 is represented solely by the level of PGH synthase. These results strongly suggest, but do not prove, the constitutive nature of the enzyme. The final demonstration requires the availability of a probe to detect mRNA level, a trial we are carrying out at the moment.

Original languageEnglish
Pages (from-to)507-513
Number of pages7
JournalExperimental Cell Research
Volume219
Issue number2
DOIs
Publication statusPublished - 1995

Fingerprint

Epoprostenol
Interleukin-1
Endothelial Cells
Enzymes
Prostaglandin-Endoperoxide Synthases
Intercellular Signaling Peptides and Proteins
Cytosolic Phospholipases A2
Prostaglandin H2
Human Umbilical Vein Endothelial Cells
Fibroblast Growth Factor 2
Microsomes
Mitogens
Arachidonic Acid
Confocal Microscopy
Interleukin-10
Prostaglandins
Fluorescent Antibody Technique
prostacyclin synthetase
Phospholipids
Protein Isoforms

ASJC Scopus subject areas

  • Cell Biology

Cite this

Prostacyclin (PGI2) synthase is a constitutively expressed enzyme in human endothelial cells. / Spisni, E.; Bartolini, G.; Orlandi, M.; Belletti, B.; Santi, S.; Tomasi, V.

In: Experimental Cell Research, Vol. 219, No. 2, 1995, p. 507-513.

Research output: Contribution to journalArticle

Spisni, E. ; Bartolini, G. ; Orlandi, M. ; Belletti, B. ; Santi, S. ; Tomasi, V. / Prostacyclin (PGI2) synthase is a constitutively expressed enzyme in human endothelial cells. In: Experimental Cell Research. 1995 ; Vol. 219, No. 2. pp. 507-513.
@article{2f35b15ac7244cb5894a959346930d5b,
title = "Prostacyclin (PGI2) synthase is a constitutively expressed enzyme in human endothelial cells",
abstract = "Biogenesis of prostanoids is under the control of some polypeptide growth factors. Cytosolic phospholipase A2, a form specific for arachidonic acid containing phospholipids, is activated by a translocation mechanism regulated by growth factors, while prostaglandin H synthase isoforms are induced de novo in several cell types. No information is available as far as PGI2 synthase is concerned. Human umbilical vein endothelial cells were cultured under conditions favoring proliferation or differentiation or capillary-like network formation in the presence of collagen gels. Basic fibroblast growth factor (bFGF 0.5-4 ng/ml) was used as a mitogen, interleukin-1α (IL-1α 10- 60 UI/ml) as a differentiating agent, and prostacyclin (PGI2) biosynthesis was evaluated. Under the first condition, basal PGI2 production was unaffected while, in the presence of IL-1α, a marked stimulation of PGI2 synthesis was observed. It is known that IL-1α is a potent inducer of PGH synthase, while it is not known whether PGI2 synthase is also induced. Two lines of evidence indicate that PGI2 synthase is a constitutively expressed not inducible enzyme: (a) proliferating nonproducing cells when added with PGH2 produce an amount of PGI2 not different from the amount produced by cells stimulated with IL-1α; (b) under this condition PGI2 synthase was immunodetectable either by immunofluorescence detected by confocal microscopy or by ELISA and, on microsomes isolated from endothelial cells, by Western blotting. It is concluded that the limiting step in the conversion arachidonate-PGI2 is represented solely by the level of PGH synthase. These results strongly suggest, but do not prove, the constitutive nature of the enzyme. The final demonstration requires the availability of a probe to detect mRNA level, a trial we are carrying out at the moment.",
author = "E. Spisni and G. Bartolini and M. Orlandi and B. Belletti and S. Santi and V. Tomasi",
year = "1995",
doi = "10.1006/excr.1995.1259",
language = "English",
volume = "219",
pages = "507--513",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Prostacyclin (PGI2) synthase is a constitutively expressed enzyme in human endothelial cells

AU - Spisni, E.

AU - Bartolini, G.

AU - Orlandi, M.

AU - Belletti, B.

AU - Santi, S.

AU - Tomasi, V.

PY - 1995

Y1 - 1995

N2 - Biogenesis of prostanoids is under the control of some polypeptide growth factors. Cytosolic phospholipase A2, a form specific for arachidonic acid containing phospholipids, is activated by a translocation mechanism regulated by growth factors, while prostaglandin H synthase isoforms are induced de novo in several cell types. No information is available as far as PGI2 synthase is concerned. Human umbilical vein endothelial cells were cultured under conditions favoring proliferation or differentiation or capillary-like network formation in the presence of collagen gels. Basic fibroblast growth factor (bFGF 0.5-4 ng/ml) was used as a mitogen, interleukin-1α (IL-1α 10- 60 UI/ml) as a differentiating agent, and prostacyclin (PGI2) biosynthesis was evaluated. Under the first condition, basal PGI2 production was unaffected while, in the presence of IL-1α, a marked stimulation of PGI2 synthesis was observed. It is known that IL-1α is a potent inducer of PGH synthase, while it is not known whether PGI2 synthase is also induced. Two lines of evidence indicate that PGI2 synthase is a constitutively expressed not inducible enzyme: (a) proliferating nonproducing cells when added with PGH2 produce an amount of PGI2 not different from the amount produced by cells stimulated with IL-1α; (b) under this condition PGI2 synthase was immunodetectable either by immunofluorescence detected by confocal microscopy or by ELISA and, on microsomes isolated from endothelial cells, by Western blotting. It is concluded that the limiting step in the conversion arachidonate-PGI2 is represented solely by the level of PGH synthase. These results strongly suggest, but do not prove, the constitutive nature of the enzyme. The final demonstration requires the availability of a probe to detect mRNA level, a trial we are carrying out at the moment.

AB - Biogenesis of prostanoids is under the control of some polypeptide growth factors. Cytosolic phospholipase A2, a form specific for arachidonic acid containing phospholipids, is activated by a translocation mechanism regulated by growth factors, while prostaglandin H synthase isoforms are induced de novo in several cell types. No information is available as far as PGI2 synthase is concerned. Human umbilical vein endothelial cells were cultured under conditions favoring proliferation or differentiation or capillary-like network formation in the presence of collagen gels. Basic fibroblast growth factor (bFGF 0.5-4 ng/ml) was used as a mitogen, interleukin-1α (IL-1α 10- 60 UI/ml) as a differentiating agent, and prostacyclin (PGI2) biosynthesis was evaluated. Under the first condition, basal PGI2 production was unaffected while, in the presence of IL-1α, a marked stimulation of PGI2 synthesis was observed. It is known that IL-1α is a potent inducer of PGH synthase, while it is not known whether PGI2 synthase is also induced. Two lines of evidence indicate that PGI2 synthase is a constitutively expressed not inducible enzyme: (a) proliferating nonproducing cells when added with PGH2 produce an amount of PGI2 not different from the amount produced by cells stimulated with IL-1α; (b) under this condition PGI2 synthase was immunodetectable either by immunofluorescence detected by confocal microscopy or by ELISA and, on microsomes isolated from endothelial cells, by Western blotting. It is concluded that the limiting step in the conversion arachidonate-PGI2 is represented solely by the level of PGH synthase. These results strongly suggest, but do not prove, the constitutive nature of the enzyme. The final demonstration requires the availability of a probe to detect mRNA level, a trial we are carrying out at the moment.

UR - http://www.scopus.com/inward/record.url?scp=0028983942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028983942&partnerID=8YFLogxK

U2 - 10.1006/excr.1995.1259

DO - 10.1006/excr.1995.1259

M3 - Article

C2 - 7641804

AN - SCOPUS:0028983942

VL - 219

SP - 507

EP - 513

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 2

ER -